Nanosuspensions of anti-retroviral agents for increased central nervous system delivery

Details for Australian Patent Application No. 2005209243 (hide)

Owner Baxter International Inc. Baxter Healthcare S.A.

Inventors Chaubal, Mahesh V.; Rabinow, Barrett E.; Werling, Jane; Kipp, James E.

Agent Peter Maxwell & Associates

Pub. Number AU-A-2005209243

PCT Pub. Number WO2005/072706

Priority 60/540,718 29.01.04 US

Filing date 21 January 2005

Wipo publication date 11 August 2005

International Classifications

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 9/51 (2006.01) Medicinal preparations characterised by special physical form - Nanocapsules

Event Publications

17 August 2006 PCT application entered the National Phase

  PCT publication WO2005/072706 Priority application(s): WO2005/072706

6 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005209244-Anterior cruciate ligament substituting knee replacement prosthesis

2005209242-Controlled and sustained delivery of nucleic acid-based therapeutic agents